These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 28396568

  • 1. Tollip Deficiency Alters Atherosclerosis and Steatosis by Disrupting Lipophagy.
    Chen K, Yuan R, Zhang Y, Geng S, Li L.
    J Am Heart Assoc; 2017 Apr 10; 6(4):. PubMed ID: 28396568
    [Abstract] [Full Text] [Related]

  • 2. Hyperlipidemia induces typical atherosclerosis development in Ldlr and Apoe deficient rats.
    Zhao Y, Yang Y, Xing R, Cui X, Xiao Y, Xie L, You P, Wang T, Zeng L, Peng W, Li D, Chen H, Liu M.
    Atherosclerosis; 2018 Apr 10; 271():26-35. PubMed ID: 29459263
    [Abstract] [Full Text] [Related]

  • 3. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y, Sukhanov S, Shai SY, Danchuk S, Tang R, Snarski P, Li Z, Lobelle-Rich P, Wang M, Wang D, Yu H, Korthuis R, Delafontaine P.
    Circulation; 2016 Jun 07; 133(23):2263-78. PubMed ID: 27154724
    [Abstract] [Full Text] [Related]

  • 4. Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E-/- Mice.
    Rinne P, Kadiri JJ, Velasco-Delgado M, Nuutinen S, Viitala M, Hollmén M, Rami M, Savontaus E, Steffens S.
    Arterioscler Thromb Vasc Biol; 2018 Feb 07; 38(2):313-323. PubMed ID: 29284608
    [Abstract] [Full Text] [Related]

  • 5. Map3k8 Modulates Monocyte State and Atherogenesis in ApoE-/- Mice.
    Sanz-Garcia C, Sánchez Á, Contreras-Jurado C, Cales C, Barranquero C, Muñoz M, Merino R, Escudero P, Sanz MJ, Osada J, Aranda A, Alemany S.
    Arterioscler Thromb Vasc Biol; 2017 Feb 07; 37(2):237-246. PubMed ID: 27856455
    [Abstract] [Full Text] [Related]

  • 6. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
    Butcher MJ, Waseem TC, Galkina EV.
    Arterioscler Thromb Vasc Biol; 2016 Aug 07; 36(8):1496-506. PubMed ID: 27365405
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X, Qian S, Hoggatt A, Tang H, Hacker TA, Obukhov AG, Herring PB, Seye CI.
    Arterioscler Thromb Vasc Biol; 2017 Jan 07; 37(1):75-83. PubMed ID: 27856454
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice.
    Selle J, Asare Y, Köhncke J, Alampour-Rajabi S, Shagdarsuren G, Klos A, Weber C, Jankowski J, Shagdarsuren E.
    Thromb Haemost; 2015 Oct 07; 114(4):848-58. PubMed ID: 26084965
    [Abstract] [Full Text] [Related]

  • 12. Heparanase promotes the onset and progression of atherosclerosis in apolipoprotein E gene knockout mice.
    Nguyen TK, Paone S, Baxter AA, Mayfosh AJ, Phan TK, Chan E, Peter K, Poon IKH, Thomas SR, Hulett MD.
    Atherosclerosis; 2024 May 07; 392():117519. PubMed ID: 38581737
    [Abstract] [Full Text] [Related]

  • 13. Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice.
    Shami A, Gustafsson R, Kalamajski S, Krams R, Segers D, Rauch U, Roos G, Nilsson J, Oldberg Å, Hultgårdh-Nilsson A.
    Arterioscler Thromb Vasc Biol; 2013 Feb 07; 33(2):354-61. PubMed ID: 23202368
    [Abstract] [Full Text] [Related]

  • 14. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [Abstract] [Full Text] [Related]

  • 15. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
    Sato K, Shirai R, Hontani M, Shinooka R, Hasegawa A, Kichise T, Yamashita T, Yoshizawa H, Watanabe R, Matsuyama TA, Ishibashi-Ueda H, Koba S, Kobayashi Y, Hirano T, Watanabe T.
    J Am Heart Assoc; 2017 Apr 14; 6(4):. PubMed ID: 28411243
    [Abstract] [Full Text] [Related]

  • 16. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
    Adamson SE, Polanowska-Grabowska R, Marqueen K, Griffiths R, Angdisen J, Breevoort SR, Schulman IG, Leitinger N.
    Arterioscler Thromb Vasc Biol; 2018 May 14; 38(5):1020-1029. PubMed ID: 29599136
    [Abstract] [Full Text] [Related]

  • 17. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.
    Karshovska E, Zhao Z, Blanchet X, Schmitt MM, Bidzhekov K, Soehnlein O, von Hundelshausen P, Mattheij NJ, Cosemans JM, Megens RT, Koeppel TA, Schober A, Hackeng TM, Weber C, Koenen RR.
    Circ Res; 2015 Feb 13; 116(4):587-99. PubMed ID: 25472975
    [Abstract] [Full Text] [Related]

  • 18. Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice.
    Yin M, Liu Q, Yu L, Yang Y, Lu M, Wang H, Luo D, Rong X, Tang F, Guo J.
    J Vasc Res; 2017 Feb 13; 54(3):123-130. PubMed ID: 28448973
    [Abstract] [Full Text] [Related]

  • 19. Fibronectin extra domain A stabilises atherosclerotic plaques in apolipoprotein E and in LDL-receptor-deficient mice.
    Pulakazhi Venu VK, Uboldi P, Dhyani A, Patrini A, Baetta R, Ferri N, Corsini A, Muro AF, Catapano AL, Norata GD.
    Thromb Haemost; 2015 Jul 13; 114(1):186-97. PubMed ID: 25881051
    [Abstract] [Full Text] [Related]

  • 20. G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE-/- mice.
    Qian L, Ma L, Wu G, Yu Q, Lin H, Ying Q, Wen D, Gao C.
    Vascul Pharmacol; 2017 Feb 13; 89():49-57. PubMed ID: 28069546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.